市場調査レポート
商品コード
1563200

バイオ医薬品発酵システムの世界市場、2033年までの機会と戦略

Biopharmaceutical Fermentation Systems Global Market Opportunities And Strategies To 2033
表紙：バイオ医薬品発酵システムの世界市場、2033年までの機会と戦略

出版日
ページ情報
英文 330 Pages
納期
2～3営業日
カスタマイズ可能
バイオ医薬品発酵システムの世界市場、2033年までの機会と戦略
出版日: 2024年09月30日
発行: The Business Research Company
ページ情報: 英文 330 Pages
納期: 2～3営業日
GIIご利用のメリット

  • 全表示

  • 概要
  • 目次
概要

世界のバイオ医薬品発酵システム市場は2018年に149億3,090万米ドルと評価され、2023年までCAGRで8.0％以上の成長を示しました。

新規生物製剤開発の増加

歴史的な期間に、新規生物製剤の開発の増加は、バイオ医薬品発酵システム市場の成長を支えました。新規生物製剤の開発の増加は、バイオテクノロジーの進歩、疾病メカニズムの理解の増加、標的療法と個別化療法の需要に起因します。バイオ医薬品発酵システムは、遺伝子操作された細胞や微生物を培養し、複雑な治療用タンパク質、抗体、ワクチンの大規模合成を可能にする生物製剤製造に使用されます。例えば、米国の医学図書館である国立医学図書館によると、2023年に米国食品医薬品局（FDA）は29の新規化学物質（NCE）と25の新規生物学的製剤（NBE）を含む55の新薬を承認し、2022年の37の承認に比べ50％増加しました。このため、新規生物製剤の開発増加がバイオ医薬品発酵システム市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

  • バイオ医薬品発酵システム-市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • バイオ医薬品発酵システム市場定義とセグメンテーション
  • 市場セグメンテーション：製品別
    • アップストリーム製品
    • ダウンストリーム製品
  • 市場セグメンテーション：用途別
    • 組み換えタンパク質
    • モノクローナル抗体
    • 抗生物質
    • プロバイオティクス
    • その他
  • 市場セグメンテーション：エンドユーザー別
    • バイオ医薬品企業
    • CMO
    • CRO
    • 学術研究機関
    • その他

第7章 主要な市場動向

  • 生産能力増強のための製造施設拡張
  • 発酵能力を高める新技術開発センター
  • シングルユースの上流工程を強化するための新しいバイオリアクターの開発

第8章 バイオ医薬品発酵システム市場：マクロ経済シナリオ

  • COVID-19の影響：バイオ医薬品発酵システム市場
  • ウクライナ戦争の影響：バイオ医薬品発酵システム市場
  • 高インフレの影響：バイオ医薬品発酵システム市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因, 2018-2023
    • 市場抑制要因, 2018-2023
  • 市場成長予測, 2023-2028, 2033F
    • 市場促進要因, 2023-2028
    • 市場抑制要因, 2023-2028

第10章 世界のバイオ医薬品発酵システム市場：セグメンテーション

  • 世界のバイオ医薬品発酵システム市場：製品別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のバイオ医薬品発酵システム市場：用途別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のバイオ医薬品発酵システム市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第11章 バイオ医薬品発酵システム市場：地域・国別分析

  • 世界のバイオ医薬品発酵システム市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のバイオ医薬品発酵システム市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Danaher Corporation
  • Thermo Fisher Scientific Inc
  • F. Hoffman-La Roche Ltd
  • Sartorius Stedim Biotech
  • Getinge Group

第20章 その他の大手企業と革新的企業

  • GE Healthcare Technologies Inc
  • Lonza Group AG
  • Agilent Technologies Inc
  • Merck Co. & KGaA
  • Charles River Laboratories
  • Nova Biomedical Corporation
  • Hamilton Company
  • Eppendorf AG
  • ZETA Holding GmbH
  • Tecan Group Ltd
  • Applikon Biotechnology
  • Parr Instrument Company
  • BioNet
  • Cellexus Ltd
  • Solaris Biotech S.r.l

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

第24章 機会と戦略

  • 新たな機会を提供する国
  • 新たな機会を提供するセグメント
  • 成長戦略

第25章 バイオ医薬品発酵システム市場：結論と提言

  • 結論
  • 提言

第26章 付録

目次
Product Code: o&s1338

Biopharmaceutical fermentation systems are specialized equipment and processes used to cultivate microorganisms or cells for the production of biopharmaceuticals. Biopharmaceutical fermentation systems are critical in scaling up from laboratory research to commercial production, enabling the efficient and safe manufacture of complex biopharmaceutical products.

The biopharmaceutical fermentation systems market consists of sales, by entities (organizations, sole traders and partnerships), of biopharmaceutical fermentation systems that are used in the production of a wide range of biologic drugs and therapies.

The global biopharmaceutical fermentation systems market was valued at $14,930.9 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 8.0%.

Rise In Development Of Novel Biologics

During the historic period, the rise in development of novel biologics supported the growth of the biopharmaceutical fermentation systems market. The rise in development of novel biologics can be attributed to advancements in biotechnology, increased understanding of disease mechanisms and the demand for targeted and personalized therapies. Biopharmaceutical fermentation systems are used in biologics production to cultivate genetically engineered cells or microorganisms, enabling the synthesis of complex therapeutic proteins, antibodies and vaccines on a large scale. For instance, according to the National Library of Medicine, a US-based medical library, in 2023, the US Food and Drug Administration (FDA) approved 55 new drugs, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs), marking a 50% increase compared to the 37 approvals in 2022. Therefore, the rise in development of novel biologics drove the growth of the biopharmaceutical fermentation systems market.

New Technology Development Centers To Enhance Fermentation Capabilities

Companies in the biopharmaceutical fermentation systems market are developing new technology development centers to enhance fermentation capabilities. These centers facilitate the development of more effective and tailored fermentation technologies, thereby improving product development and manufacturing processes. For instance, in July 2023, Praj HiPurity Systems, an India-based company that provides end-to-end turnkey solutions for the biopharma industry, announced plans to establish a Technology Development Center to advance its fermentation technology capabilities. This initiative is driven by the growing demand for fermentation-based products in the pharmaceutical and biopharmaceutical industries. The center will focus on addressing customer challenges, especially in the complex injectable segment and will work on optimizing fermentation solutions to better meet industry needs.

The global biopharmaceutical fermentation systems market is fairly fragmented, with a large number of small players operating in the market. The top ten competitors in the market made up to 20.70% of the total market in 2023.

Biopharmaceutical Fermentation Systems Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global biopharmaceutical fermentation systems market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for biopharmaceutical fermentation systems? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The biopharmaceutical fermentation systems market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider biopharmaceutical fermentation systems market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by application and by end-users.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the biopharmaceutical fermentation systems market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by application and by end-users in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for biopharmaceutical fermentation systems providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Upstream Products; Downstream Products
  • 2) By Application: Recombinant Proteins; Monoclonal Antibodies; Antibiotics; Probiotics And Other Applications
  • 3) By End-User: Biopharmaceutical Companies; Contract Manufacturing Organizations; Contract Research Organizations; Academic Research Institutes; Other End-Users
  • Companies Mentioned: Danaher Corporation; Thermo Fisher Scientific Inc.; F. Hoffmann-La Roche Ltd.; Sartorius Stedim Biotech; Getinge Group
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; biopharmaceutical fermentation systems indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 Biopharmaceutical Fermentation Systems - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 Biopharmaceutical Fermentation Systems Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Upstream Products
    • 6.4.2 Downstream Products
  • 6.5 Market Segmentation By Application
    • 6.5.1 Recombinant Proteins
    • 6.5.2 Monoclonal Antibodies
    • 6.5.3 Antibiotics
    • 6.5.4 Probiotics
    • 6.5.5 Other Applications
  • 6.6 Market Segmentation By End-Users
    • 6.6.1 Biopharmaceutical Companies
    • 6.6.2 Contract Manufacturing Organizations
    • 6.6.3 Contract Research Organizations
    • 6.6.4 Academic Research Institutes
    • 6.6.5 Other End-Users

7 Major Market Trends

  • 7.1 Expansion Of Manufacturing Facility To Enhance Production Capacity
  • 7.2 New Technology Development Centers To Enhance Fermentation Capabilities
  • 7.3 Development Of New Bioreactors To Enhance Single-Use Upstream Operations

8 Biopharmaceutical Fermentation Systems Market - Macro-Economic Scenario

  • 8.1 COVID-19 Impact On The Biopharmaceutical Fermentation Systems Market
  • 8.2 Impact Of The War In Ukraine On The Biopharmaceutical Fermentation Systems Market
  • 8.3 Impact Of High Inflation On The Biopharmaceutical Fermentation Systems Market

9 Global Market Size And Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global Biopharmaceutical Fermentation Systems Market Segmentation

  • 10.1 Global Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Biopharmaceutical Fermentation Systems Market, Regional and Country Analysis

  • 11.1 Global Biopharmaceutical Fermentation Systems Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global Biopharmaceutical Fermentation Systems Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
  • 12.2 Market Overview
    • 12.2.1 Region Information
    • 12.2.2 Market Information
    • 12.2.3 Background Information
    • 12.2.4 Government Initiatives
    • 12.2.5 Regulations
    • 12.2.6 Regulatory Bodies
    • 12.2.7 Major Associations
    • 12.2.8 Taxes Levied
    • 12.2.9 Corporate Tax Structure
    • 12.2.10 Investments
    • 12.2.11 Major Companies
  • 12.3 Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.6 Asia-Pacific Biopharmaceutical Fermentation Systems Market: Country Analysis
  • 12.7 China Market
  • 12.8 Summary
  • 12.9 Market Overview
    • 12.9.1 Country Information
    • 12.9.2 Market Information
    • 12.9.3 Background Information
    • 12.9.4 Government Initiatives
    • 12.9.5 Regulations
    • 12.9.6 Regulatory Bodies
    • 12.9.7 Major Associations
    • 12.9.8 Taxes Levied
    • 12.9.9 Corporate Tax Structure
    • 12.9.10 Investments
    • 12.9.11 Major Companies
  • 12.10 China Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 China Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.12 China Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India Market
  • 12.14 India Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 India Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.16 India Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan Market
  • 12.18 Japan Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Japan Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.20 Japan Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia Market
  • 12.22 Australia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Australia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.24 Australia Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia Market
  • 12.26 Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.28 Indonesia Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea Market
  • 12.30 South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.31 South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.32 South Korea Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
  • 13.2 Market Overview
    • 13.2.1 Region Information
    • 13.2.2 Market Information
    • 13.2.3 Background Information
    • 13.2.4 Government Initiatives
    • 13.2.5 Regulations
    • 13.2.6 Regulatory Bodies
    • 13.2.7 Major Associations
    • 13.2.8 Taxes Levied
    • 13.2.9 Corporate Tax Structure
    • 13.2.10 Investments
    • 13.2.11 Major Companies
  • 13.3 Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.6 Western Europe Biopharmaceutical Fermentation Systems Market: Country Analysis
  • 13.7 UK Market
  • 13.8 UK Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 UK Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.11 Germany Market
  • 13.12 Germany Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 Germany Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.15 France Market
  • 13.16 France Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 France Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.19 Italy Market
  • 13.20 Italy Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Italy Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.23 Spain Market
  • 13.24 Spain Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.26 Spain Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
  • 14.2 Market Overview
    • 14.2.1 Region Information
    • 14.2.2 Market Information
    • 14.2.3 Background Information
    • 14.2.4 Government Initiatives
    • 14.2.5 Regulations
    • 14.2.6 Regulatory Bodies
    • 14.2.7 Major Associations
    • 14.2.8 Taxes Levied
    • 14.2.9 Corporate Tax Structure
    • 14.2.10 Major Companies
  • 14.3 Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.6 Eastern Europe Biopharmaceutical Fermentation Systems Market: Country Analysis
  • 14.7 Russia Market
  • 14.8 Russia Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.10 Russia Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
  • 15.2 Market Overview
    • 15.2.1 Region Information
    • 15.2.2 Market Information
    • 15.2.3 Background Information
    • 15.2.4 Government Initiatives
    • 15.2.5 Regulations
    • 15.2.6 Regulatory Bodies
    • 15.2.7 Major Associations
    • 15.2.8 Taxes Levied
    • 15.2.9 Corporate Tax Structure
    • 15.2.10 Investments
    • 15.2.11 Major Companies
  • 15.3 North America Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.6 North America Biopharmaceutical Fermentation Systems Market: Country Analysis
  • 15.7 USA Market
  • 15.8 Summary
  • 15.9 Market Overview
    • 15.9.1 Country Information
    • 15.9.2 Market Information
    • 15.9.3 Background Information
    • 15.9.4 Government Initiatives
    • 15.9.5 Regulations
    • 15.9.6 Regulatory Bodies
    • 15.9.7 Major Associations
    • 15.9.8 Taxes Levied
    • 15.9.9 Corporate Tax Structure
    • 15.9.10 Investments
    • 15.9.11 Major Companies
  • 15.10 USA Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 USA Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.12 USA Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada Market
  • 15.14 Canada Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.15 Canada Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.16 Canada Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
  • 16.2 Market Overview
    • 16.2.1 Region Information
    • 16.2.2 Market Information
    • 16.2.3 Background Information
    • 16.2.4 Government Initiatives
    • 16.2.5 Regulations
    • 16.2.6 Regulatory Bodies
    • 16.2.7 Major Associations
    • 16.2.8 Taxes Levied
    • 16.2.9 Corporate Tax Structure
    • 16.2.10 Investments
    • 16.2.11 Major Companies
  • 16.3 South America Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.6 South America Biopharmaceutical Fermentation Systems Market: Country Analysis
  • 16.7 Brazil Market
  • 16.8 Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.10 Brazil Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
  • 17.2 Market Overview
    • 17.2.1 Region Information
    • 17.2.2 Market Information
    • 17.2.3 Background Information
    • 17.2.4 Government Initiatives
    • 17.2.5 Regulations
    • 17.2.6 Regulatory Bodies
    • 17.2.7 Major Associations
    • 17.2.8 Taxes Levied
    • 17.2.9 Corporate Tax Structure
    • 17.2.10 Investments
    • 17.2.11 Major Companies
  • 17.3 Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.5 Middle East Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Major Companies
  • 18.3 Africa Biopharmaceutical Fermentation Systems Market, Segmentation By Product, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa Biopharmaceutical Fermentation Systems Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa Biopharmaceutical Fermentation Systems Market, Segmentation By End-Users, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Danaher Corporation
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.3 Thermo Fisher Scientific Inc
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial Overview
  • 19.4 F. Hoffman-La Roche Ltd
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial Overview
  • 19.5 Sartorius Stedim Biotech
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Business Strategy
    • 19.5.4 Financial Overview
  • 19.6 Getinge Group
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial Overview

20 Other Major And Innovative Companies

  • 20.1 GE Healthcare Technologies Inc
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Lonza Group AG
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 Agilent Technologies Inc
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Merck Co. & KGaA
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Charles River Laboratories
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 Nova Biomedical Corporation
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 Hamilton Company
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 Eppendorf AG
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 ZETA Holding GmbH
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Tecan Group Ltd
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Applikon Biotechnology
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Parr Instrument Company
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 BioNet
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Cellexus Ltd
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 Solaris Biotech S.r.l
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Polaris Group Acquired Genovior Biotech
  • 23.2 Lifera Acquired Saudi Biotechnology Manufacturing Co.
  • 23.3 Croda International Plc Acquired Solus Biotech
  • 23.4 Wacker Chemie Acquired ADL BioPharma

24 Opportunities And Strategies

  • 24.1 Global Biopharmaceutical Fermentation Systems Market In 2028 - Countries Offering Most New Opportunities
  • 24.2 Global Biopharmaceutical Fermentation Systems Market In 2028 - Segments Offering Most New Opportunities
  • 24.3 Global Biopharmaceutical Fermentation Systems Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 Biopharmaceutical Fermentation Systems Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer